1.3.1.74	Neoplasms	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14977853&form=6&db=m	NADPH alkenal/one oxidoreductase activity determines sensitivity of cancer cells to the chemotherapeutic alkylating agent irofulven.	ongoing research,therapeutic application,unassigned	3,2,0	
1.3.1.74	Neoplasms	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16857669&form=6&db=m	Nrf2-mediated induction of cytoprotective enzymes by 15-deoxy-Delta12,14-prostaglandin J2 is attenuated by alkenal/one oxidoreductase.	therapeutic application,unassigned	4,0	
1.3.1.74	Neoplasms	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24853774&form=6&db=m	Increased expression of prostaglandin reductase 1 in hepatocellular carcinomas from clinical cases and experimental tumors in rats.	causal interaction,ongoing research,unassigned	4,2,0